Kennedy Capital Management, Inc. Chembio Diagnostics, Inc. Transaction History

Kennedy Capital Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 16, 2020	SELL	$3.28 - $5.93 $1.87 Million - $3.38 Million	-570,113 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.18 - $15.54 $1.81 Million - $8.86 Million	570,113 New	570,113 $1.85 Million

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.